Skip to content
Disclosery

DCVC Opportunity Fund II GP, LLC

Follow

13F filer, CIK 1668343, PALO ALTO, CA

DCVC Opportunity Fund II GP, LLC reported $97,375,768 across 3 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-118270

Period
2024-09-30
Reported value
$97.4M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2024

Share positions as resolved from 13F-HR 0001104659-24-118270, largest first. % of portfolio is the value over $97,375,768, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ROCKET LAB USA INCROCKET LAB USA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,203,035 shares 7,203,035$70.1M71.97%0
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,951,141 shares 3,951,141$26M26.74%0Timeline
RGTIRIGETTI COMPUTING INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,599,052 shares 1,599,052$1.25M1.29%0Timeline

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-118270 base2024-11-14acceptance time not in the bulk data set